Tu banner alternativo

Azapropazone

This article will address the topic of Azapropazone, which represents a fundamental aspect in people's lives. Since time immemorial, Azapropazone has been the object of study, debate and reflection, due to its impact on various areas of society. Throughout history, Azapropazone has played a crucial role in the development of humanity, influencing the way people interact, think, and relate to each other. Therefore, it is essential to delve into the different aspects that Azapropazone encompasses, from its origins to its relevance today, in order to understand its importance and significance in the contemporary context.

Tu banner alternativo
Azapropazone
Azapropazone molecule
Clinical data
Trade namesRheumox
AHFS/Drugs.comInternational Drug Names
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
Pharmacokinetic data
Elimination half-life20 hours
Identifiers
  • (RS)-5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolobenzotriazine-1,3(2H)-dione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.033.543 Edit this at Wikidata
Chemical and physical data
FormulaC16H20N4O2
Molar mass300.362 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • O=C3N/1N(c2c(\N=C\1N(C)C)ccc(c2)C)C(=O)C3CCC
  • InChI=1S/C16H20N4O2/c1-5-6-11-14(21)19-13-9-10(2)7-8-12(13)17-16(18(3)4)20(19)15(11)22/h7-9,11H,5-6H2,1-4H3 checkY
  • Key:MPHPHYZQRGLTBO-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Azapropazone is a nonsteroidal anti-inflammatory drug (NSAID). It is manufactured by Goldshield under the tradename Rheumox.[1]

It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.

Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]

References

  1. ^ "Rheumox Capsules". South Africa Electronic Package Inserts. Archived from the original on 2008-05-15. Retrieved 2008-08-18.
  2. ^ "Azapropazone". Patient UK. Archived from the original on 12 April 2009.
  3. ^ Jones CJ (1976). "The pharmacology and pharmacokinetics of azapropazone - a review". Current Medical Research and Opinion. 4 (1): 3–16. doi:10.1185/03007997609109277. PMID 770078.
Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia